S1196
α-Synuclein A30P human
recombinant, expressed in E. coli, N-terminal histidine tagged, ≥90% (SDS-PAGE), lyophilized powder
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
About This Item
Ricombinante
expressed in E. coli
Saggio
≥90% (SDS-PAGE)
Forma fisica
lyophilized powder
N° accesso UniProt
Condizioni di spedizione
dry ice
Temperatura di conservazione
−20°C
Informazioni sul gene
human ... SNCA(6622)
Descrizione generale
Alpha synuclein (SNCA) SNCA is a protein made up of 140 amino acids and is coded by 5 exons. It belongs to the synuclein family. SNCA gene is mapped to human chromosome 4q22.1.
Applicazioni
α-Synuclein A30P human has been used to inject it stereotaxically into substantia nigra (SN) of mice to study its effects on meningeal lymphatic drainage and its association with Parkinson′s disease (PD).
Azioni biochim/fisiol
Alpha synuclein (SNCA) is associated with Lewy bodies′ disease (LBD), Alzheimer′s disease (AD) and muscular system atrophy (MSA).
A point mutation in the α-synuclein gene, Ala30-Pro (A30P), linked to familial Parkinson′s disease.
Codice della classe di stoccaggio
11 - Combustible Solids
Classe di pericolosità dell'acqua (WGK)
WGK 3
Punto d’infiammabilità (°F)
Not applicable
Punto d’infiammabilità (°C)
Not applicable
Dispositivi di protezione individuale
Eyeshields, Gloves, type N95 (US)
Certificati d'analisi (COA)
Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
I clienti hanno visto anche
Mosaicism of alpha-synuclein gene rearrangements: report of two unrelated cases of early-onset parkinsonism.
C Perandones et al.
Parkinsonism & related disorders, 20(5), 558-561 (2014-02-21)
The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication.
Irum Javaid Siddiqui et al.
Scientific reports, 6, 24475-24475 (2016-04-16)
After Alzheimer, Parkinson's disease (PD) is the second most common neurodegenerative disorder. Alpha synuclein (SNCA) is deemed as a major component of Lewy bodies, a neuropathological feature of PD. Five point mutations in SNCA have been reported so far, responsible
Muhammad Abdul Alim et al.
Journal of Alzheimer's disease : JAD, 6(4), 435-442 (2004-09-04)
Alpha-synuclein is a major constituent of pathological intracellular inclusion bodies, a common feature of several neurodegenerative diseases. Two missense mutations in the alpha-synuclein gene have been identified in confirmed autosomal-dominant familial Parkinson's disease, which segregate with the illness. However, the
M H Polymeropoulos et al.
Science (New York, N.Y.), 276(5321), 2045-2047 (1997-06-27)
Parkinson's disease (PD) is a common neurodegenerative disorder with a lifetime incidence of approximately 2 percent. A pattern of familial aggregation has been documented for the disorder, and it was recently reported that a PD susceptibility gene in a large
Wenyan Zou et al.
Translational neurodegeneration, 8, 7-7 (2019-03-15)
Abnormal aggregation of brain α-synuclein is a central step in the pathogenesis of Parkinson's disease (PD), thus, it is reliable to promote the clearance of α-synuclein to prevent and treat PD. Recent studies have revealed an essential role of glymphatic
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.